Streetbeat News

Stock Prices

SMMT

Summit Therapeutics (NASDAQ:SMMT) stock surged 8% after receiving marketing authorization in China for ivonescimab in combination with chemotherapy, based on promising Phase III trial results. Additionally, Summit raised $200 million through an unsolicited stock offer.

Portfolio Pulse from Dylan Berman

June 03, 2024 | 4:00 pm

NVCR

NovoCure shares are trading higher after the company announced that the phase 3 METIS trial met its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 3:54 pm

TLT

UUP

U.S. manufacturing activity contracted more than expected in May, leading to a decline in Treasury yields and a weakening of the U.S. dollar. The iShares 20+ Year Treasury Bond ETF (TLT) rallied by 0.9%, while the Invesco DB USD Index Bullish Fund ETF (UUP) fell by 0.4%. Traders increased their bets on a September rate cut.

Portfolio Pulse from Piero Cingari

June 03, 2024 | 3:50 pm

DNLI

Denali Therapeutics shares are trading higher after the FDA selected DNL126 for participation in the Support for clinical Trials Advancing Rare disease Therapeutics Pilot Program.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 3:49 pm

VALN

Valneva SE announced that the results of two Phase 2 clinical trials for its Lyme disease vaccine candidate, VLA15, have been published in 'The Lancet Infectious Diseases'. These trials, along with a third Phase 2 trial in pediatric participants, support the design of the current pivotal Phase 3 trial, VALOR.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 3:46 pm

ARWR

Arrowhead Pharmaceuticals shares are trading higher following positive topline results from the Phase 3 PALISADE study of plozasiran in patients with familial chylomicronemia syndrome. The company also met all key secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 3:46 pm

NOVA

Sunnova Energy International Inc (NYSE:NOVA) shares surged by 12.3% to $5.86 despite no specific news justifying the rise. The company announced the resignation of Rahman D’Argenio from its Board of Directors and Compensation and Human Capital Committee, effective June 28. ECP Stockholder confirmed the resignation but did not nominate a replacement.

Portfolio Pulse from Henry Khederian

June 03, 2024 | 3:42 pm

DJIA

NDAQ

QQQ

SPY

The New York Stock Exchange (NYSE) has resolved a technical issue that temporarily halted trading for certain stocks. All impacted stocks have now reopened, and the systems are fully operational.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 3:42 pm

GPCR

Structure Therapeutics shares are trading higher following the release of topline data from its Phase 2a study of GSBR-1290.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 3:38 pm

BRK/A

Berkshire Hathaway shares resumed trading after a technical glitch on the NYSE caused a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 3:37 pm